HIV (Human Immunodeficiency Virus) continues to be a major global health challenge, affecting millions of people worldwide. Despite significant advancements in antiretroviral therapy (ART), which have dramatically improved life expectancy and quality of life for those infected, the search for a definitive cure and effective preventive strategies remains crucial. This narrative review aims to explore the latest innovations in HIV treatment and control. It highlights cutting-edge genetic engineering techniques such as CRISPR-Cas9 and various gene therapy approaches that show potential in eradicating latent viral reservoirs, a key obstacle in curing HIV. Additionally, the development of new vaccines targeting multiple stages of the HIV life cycle is discussed, focusing on their ability to stimulate robust and long-lasting immune responses. The review also examines recent advances in drug formulations, including long-acting antiretroviral drugs and immune-enhancing therapies, designed to improve treatment adherence and patient outcomes. Furthermore, challenges like emerging viral resistance, social and economic factors affecting adherence, and the urgent need for international collaboration in research are analyzed. Ultimately, the future of HIV management lies in integrating these scientific advancements with comprehensive public health initiatives to improve clinical outcomes and reduce transmission globally. This review underscores the importance of ongoing research and highlights promising avenues toward sustained control and eventual eradication of HIV infection.